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Vaccines against two high-risk human papillomavirus (HPV) types, HPV-16 and HPV-18, are 
in use currently, with high efficacy in preventing infections with these HPV types and 
consequent cervical cancers. However, circulating HPV types can vary with geography and 
ethnicity. The aim of this study was to investigate the prevalence of HPV types and the 
association between HPV types and abnormal cervical cytology among female sex workers in 
Northern Vietnam. Cervical swabs and plasma samples were collected from 281 female sex 
workers at two health centers in Hanoi and Hai Phong in 2009. The HPV L1 gene was 
amplified by PCR using original and modified GP5+/6+ primers. Amplified PCR products 
were genotyped by the microarray system geneSQUARE (KURABO) and/or clonal 
sequencing. Of the 281 women, 139 (49.5%) were positive for HPV DNA. Among the HPV-
positive samples, 339 strains and 29 different types were identified. Multiple-type and high 
risk-type HPV infections were found in 85 (61.2%) and 124 (89.2%) women, respectively. 
The most common genotype was HPV-52, followed by HPV-16, HPV-18, and HPV-58. 
Abnormal cervical cytology was detected in 3.2% (9/281) of the women, and all of these 
samples were positive for HPV-DNA. Age ≤ 25 years and infection with human 
immunodeficiency virus were associated positively with HPV infection among the women 
while ever smoking was associated negatively. These results show that HPV-52 is most 
prevalent among female sex workers in Northern Vietnam, most of whom had normal 





Genital human papillomavirus (HPV) infection is the most common infection transmitted 
sexually among women and the main cause of cervical cancer worldwide, especially in 
developing countries, where 85% of cervical cancer cases occur [Ferlay et al., 2010]. There 
were an estimated 529,000 new cases and 275,000 cervical cancer–related deaths globally in 
2008, including 312,000 (59%) new cases in Asia, and HPV infections are prevalent 
particularly in South and Southeast Asia [Ferlay, 2010; WHO, 2010]. Cervical cancer 
screening using cytological testing and HPV vaccination are of paramount importance for 
preventing cervical cancer in young women. 
HPV belongs to the family Papillomaviridae. More than 100 distinct HPV genotypes 
have been characterized molecularly, and about 40 HPV types have been identified in the 
mucosal epithelia of the human genital tract [Munoz et al., 2006]. Cervical cancer is caused 
by HPV types that belong to a few “high-risk” species of the mucosotropic alpha genus, such 
as alpha-5, -6, -7, -9, and -11 [Bouvard et al., 2009; Schiffman 2010]. Eight HPV types 
(HPV-16, -18, -31, -33, -35, -45, -52, and -58) are observed most frequently and are 
responsible for about 90% of all cases of cervical cancer worldwide [Munoz et al., 2006]. In 
particular, HPV-16 and HPV-18 are observed in 70% of cervical cancer cases worldwide 
[Munoz et al., 2003; Clifford et al., 2006]. 
Current prophylactic HPV vaccines targeting HPV-16 and HPV-18 hold great 
promise for reducing the global burden of cervical cancer [Harper et al., 2006; Wheeler, 
2007]. However, circulating HPV types can vary by geography and ethnicity, and the current 
vaccine formulary for these two high-risk types is less effective against some other oncogenic 
HPV types, although a recent study has shown cross-protective efficacy of the HPV-16/18 
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vaccine against oncogenic HPV types such as HPV-31, HPV-33, HPV-45, and HPV-51 
[Wheeler, 2012]. In Europe and America, HPV-16 and HPV-18 are the most common HPV 
types [Clifford et al., 2005] whereas in Asia, in addition to HPV-16, HPV-52 and HPV-58 are 
most common [Bao et al., 2008]. Particularly in Japan, the Philippines, Taiwan, and the 
Zhejiang province of southeast China, HPV-52 is reported to be the HPV type identified most 
frequently [Lin et al., 2006; de Sanjosé et al., 2007; Miyashita et al., 2009; Ye et al., 2010]. 
Thus, an understanding of the geographical distribution of HPV types is necessary to estimate 
vaccine efficacy accurately and prevent HPV infection and the subsequent development of 
cervical cancer. 
In Vietnam, more than 6,000 new cases of cervical cancer (incidence rate: 11.7 per 
100,000 women per year) and 3,000 cervical cancer–related deaths are estimated to occur 
each year. Cervical cancer ranks as the second most common cancer in women ages 15–45 
years [Domingo et al., 2008]. Screening for cervical cancer with the Pap smear test and HPV 
DNA detection are not available widely in Vietnam [WHO, 2002]. Previous studies identified 
HPV-16 and HPV-58 as the most common high-risk HPV types in a general population of 
Vietnamese women [Pham et al., 2003; Domingo et al., 2008] while another study reported 
that HPV-52 was the most common type among female sex workers in Southern Vietnam 
[Hernandez et al., 2008]. However, population-based information on the distribution of HPV 
types among Vietnamese women is limited still [Bao et al., 2008]. In the current study, the 
prevalence of HPV infection, the distribution of HPV types, and risk factors for HPV 
infection among female sex workers in Northern Vietnam were determined. The association 
between HPV types and abnormal cervical cytology was also investigated.  
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SUBJECTS AND METHODS 
Subjects and Sample Collection 
A cross-sectional survey of HPV infection and genotype distribution among female sex 
workers in Northern Vietnam was conducted from June to November 2009. The 281 
participants (mean age ± SD: 27.6 ± 8.0 years) had been commercial sex workers previously 
and were concentrated in two rehabilitation centers in Hanoi and Hai Phong, the largest cities 
in Northern Vietnam. They were recruited after giving written informed consent. A 
gynecological examination was performed, and two cervical-swab samples were collected 
using a cervical brush (Honest Uterine Cervical Brushes; Honest Medical, Tokyo, Japan). The 
cervical swabs were smeared onto a slide, fixed with alcohol solution (Rapid Fix; Muto, 
Tokyo, Japan), and stained according to standard procedures for the Pap smear test. The 
remainder of each sample was suspended in 1 ml of lysis buffer (TBE buffer, 50 mM Tris-
HCl, 5 mM EDTA, 2% SDS) and stored at −80°C until use. Sociodemographic information 
was collected using questionnaires. Blood samples were collected and plasma samples stored 
at −80°C until use. The study protocol was reviewed and approved by the board of the 
Ministry of Health of Vietnam and by the ethics committee of Kanazawa University, Japan. 
 
DNA Extraction  
Genomic DNA was extracted from cervical cells in lysis buffer using a DNA extraction kit 
(SMI Test; Genome Science Laboratories, Fukushima, Japan) according to the 
manufacturer’s instructions. The quality of the extracted DNA was evaluated by amplifying 
the glyceraldehyde-3-phosphate dehydrogenase gene (primers: 5′-
ACCACAGTCCATGCCATCAC-3′ and 5′-TCCACCACCCTGTTGCTGTA-3′) (Fujimori et 
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al., 2002). All extracted DNA samples were confirmed as adequate for HPV, Chlamydia (C.) 
trachomatis, and Neisseria (N.) gonorrhoeae testing. 
 
HPV Detection  
HPV DNA was detected by PCR using three pairs of modified GP5+/6+ primers: GP5+M1-2 
(5′-TTTRTTACTGTTGTWGATACTAC-3′) and GP5+M2-2 (5′-
TGTWACTGTTGTWGATACCAC-3′); GP5+M3-2 (5′-GTWACTGTTGTRGACACCAC-3′) 
and GP6+M1-2 (5′-AATTGAAAWATAAACTGTAAWTCATATTC-3′); and GP6+M2-2 (5′-
GAAACATAAAYTGTAAATCAWATTC-3′) and GP6+M3 (5′-
GAAAATYTGCAAATCAWACTC-3′) [Yamada et al., 2008; Miyashita et al., 2009]. These 
modified GP5+/6+ primers were designed to minimize mismatches between primer sequences 
and complement target HPV L1 genes and to amplify a 140-bp fragment of the HPV L1 gene. 
Amplification was performed as follows: one cycle at 95°C for 10 min, followed by 45 cycles 
at 95°C for 30 s, 45°C for 30 s, and 74°C for 30 s, with a final extension at 74°C for 10 min. 
The presence of HPV DNA was confirmed by ethidium bromide staining of the PCR products 
following agarose gel electrophoresis. PCR was repeated using the original GP5+/GP6+ 
primers for the HPV DNA–negative samples [de Roda Husman et al., 1995]. 
 
HPV Genotyping  
HPV genotyping was performed with a DNA microarray system, KURABO GeneSquare 
microarray (KURABO, Okayama, Japan), which uses multiplex PCR targeting different 
genes from type to type [Ermel et al., 2010]. The sensitivity and specificity of the 
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GeneSquare is equal reportedly to that of the Roche Linear Array HPV Genotyping Assay. 
The GeneSquare microarray contains 23 type-specific probes: HPV-6, -11,-16, -18, -30, -31, -
33, -34, -35, -39, -40, -42, -45, -51, -52, -53, -54, -56, -58, -59, -61, -66, and -68.  
The original and/or modified GP5+/6+ PCR products of the samples that were not 
genotyped by the GeneSquare microarray were cloned using the TOPO TA Cloning Kit 
(Invitrogen, Carlsbad, CA, USA) and sequenced according to the manufacturer’s instructions. 
The similarity between the L1 sequences obtained from the PCR products and those of 
various HPV genotypes registered in the GenBank database was determined by BLAST 
analysis (http://www.ncbi.nlm.nih.gov/BLAST/). 
HPV types that belong to the mucosotropic alpha genus were classified as high-risk 
types (HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -59, -68) or possibly high-risk 
types (HPV-26, -53, -66, -67, -69, -70, -73, -82, -85, -97) according to the classification of 
the International Agency for Research on Cancer [Bouvard et al., 2009], or as low-risk types 
(HPV-6, -11, -40, -42, -43, -44, -54, -55, -61, -62, -72, -81, -83, -84, -89) [Munoz et al., 2003] 
or unknown-risk types (HPV-2, -3, -7, -10, -13, -27, -28, -29, -30, -32, -34, -55, -57, -62 -71, 
-74, -77, -78, -85, -86, -87, -90, -91, 94, 102, 106) [Schiffman et al., 2010]. 
 
Detection of Infections Transmitted Sexually or Blood Borne   
Anti–human immunodeficiency virus (HIV; a member of the lentivirus genus in the family 
Retroviridae) antibody, anti–hepatitis C virus (HCV; a member of the hepacivirus genus in the 
family Flaviviridae) antibody, and hepatitis B virus (HBV; a member of the orthohepadnavirus 
genus in the family of Hepadnaviridae) surface antigen were tested using serological test kits 
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(Abbott, Tokyo, Japan). C. trachomatis and N. gonorrhoeae were detected using the loop-
mediated isothermal amplification method [Hong et al., 2004; Poon et al., 2005]. 
 
Classification of Cervical Cytology 
The Bethesda Reporting System 2001 was used to classify cervical cytology [Solomon et al., 
2002] as normal (negative for intraepithelial lesion or malignancy), atypical glandular 
cells/atypical squamous cells of undetermined significance, low-grade squamous intraepithelial 
lesion, high-grade squamous intraepithelial lesion, or adenocarcinoma in situ. 
 
Statistical Analysis 
Statistical analysis was performed using SPSS Version 19.0 for Windows. The chi-square test 
and/or Fisher’s exact test were used for comparisons between HPV DNA–positive and –
negative groups, and univariate analysis was performed to assess the association between 
HPV DNA–positive results and risk factors or other infections. A multivariate analysis was 
performed by using a stepwise binary logistic regression model to confirm the association. P 




Profile of Cervical HPV Infection 
Of the 281 women, 139 (49.5%) were positive for HPV DNA. Of these, 54 (38.8%) were 
infected with a single HPV type, and 85 (61.2%) were infected with multiple types. Multiple-
type HPV infection was more common in women ≤ 25 years than in those > 25 years old 
(OR: 2.1; 95% CI: 1.3–2.6), and also more common in women infected with HIV than in 
women without HIV infection (OR: 2.2; 95% CI: 1.1–4.4). From the 139 HPV DNA–positive 
samples, 339 HPV strains and 29 different genotypes were isolated (Figure 1). Of the 339 
strains, 228 (67.3%) were high-risk, 27 (8.0%) possible high-risk, 54 (15.9%) low-risk, and 
30 (8.8%) unknown-risk HPV types. Infection with high-risk HPV types was found in 89.2% 
(124/139) of the women infected with HPV. Among the high-risk HPV types, HPV-52 was 
the most common type (28.1%; 39/139), followed by HPV-16 (18.7%; 26/139), HPV-18 
(16.5%; 23/139), HPV-51 (16.5%; 23/139), and HPV-58 (16.5%; 23/139). 
 
Prevalence of Infections Transmitted Sexually or Blood Borne  
The 281 women were tested for infections transmitted sexually or blood borne, such as 
infections with HIV, HBV, HCV, N. gonorrhoeae, and C. trachomatis. Of the 281 women, 
177 (63.0%) had at least one infection. The prevalence of these infections was 12.8% 
(36/281) for HIV-1, 6.8% (19/281) for HBV, 18.5% (52/281) for HCV, 1.4% (4/281) for N. 
gonorrhoeae, and 6.8% (19/281) for C. trachomatis. 
 
Risk Factors for Cervical HPV Infection  
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To determine the risk factors associated with cervical HPV infection, a univariate analysis 
was performed. Age ≤ 25 years (OR: 2.2; 95% CI: 1.4–3.6), being single (OR: 1.9; 95% CI: 
1.2–3.1), smoking (OR: 0.6; 95% CI: 0.3–0.9), and HIV infection (OR: 4.2; 95% CI: 1.2–3.1) 
were associated significantly with HPV infection (Table I). When all of the variables were 
adjusted for multivariate analysis, age ≤ 25 years (OR: 2.3; 95% CI: 1.4–3.9), smoking (OR: 
0.5; 95% CI: 0.3–0.8), and HIV infection (OR: 7.9; 95% CI: 3.1–20.2) were confirmed as 
independent factors predicting high-risk HPV infection.  
 
Association between High-risk HPV Types and Abnormal Cervical Cytology 
Of the 281 women, 272 (96.8%) had normal cervical cytology, four (1.4%) had atypical 
glandular cells/atypical squamous cells of undetermined significance, and five (1.8%) had 
abnormal cervical cytology (four with a low-grade squamous intraepithelial lesion and one 
with a high-grade squamous intraepithelial lesion) with the Pap smear test. HPV DNA was 
detected in the four women with atypical glandular cells/atypical squamous cells of 
undetermined significance, as well as in the five women with abnormal cervical cytology. All 
of them were infected with high-risk HPV types (Table II). 
 
Sequence Data 
The sequences described in this report have been deposited in GenBank/EMBL/DDBJ under 




In the current study, the prevalence of cervical HPV infection among female sex workers in 
Northern Vietnam was 49.5%. This value is lower than the prevalence reported for a similar 
population in Southern Vietnam (85%) in 2008 [Hernandez et al., 2008]. The difference may 
reflect the previous finding that HPV prevalence among the general population of women in 
Southern Vietnam is 5-fold higher than in Northern Vietnam [Pham et al., 2003]. 
Nevertheless, the HPV prevalence in this study is similar to that among female sex workers in 
other Asian countries, such as the Philippines (57.2%) [Miyashita et al., 2009], Japan (52.6%) 
[Matsushita et al., 2011], and Korea (47%) [Choi et al., 2003]. A similar HPV prevalence 
among female sex workers was reported in Kenya (55.6%) [Luchters et al., 2010], Tunisia 
(44.1%) [Znazen et al., 2010], Peru (50.6%) [Montano et al., 2011], and Mexico (48.9%) 
[Juárez-Figueroa et al., 2001]. A lower HPV prevalence among female sex workers was 
reported in Spain (39%) [del Amo et al., 2005] and Australia (32%) [Tideman et al., 2003].  
 HPV-52 was found to be the most prevalent HPV type among female sex workers in 
Northern Vietnam, most of whom had normal cervical cytology. This result is consistent with 
those of a previous study of female sex workers in Southern Vietnam [Hernandez et al., 
2008], as well as with results from other Asian regions, such as South Taiwan [Lin et al., 
2006], the Philippines [Miyashita et al., 2009], and Japan [Matsushita et al., 2011]. These 
findings suggest that HPV-52 is common in Asian countries in general, although HPV-16 has 
been reported to be the most prevalent type in Asia except for Japan and Taiwan [de Sanjose 
et al., 2007; Bruni 2010]. 
 It was reported previously that HPV-16 is the most common HPV type among the 
general population of Vietnamese women; those results were obtained using the original 
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GP5+/GP6+ primers and an enzyme immunoassay for genotyping [Pham et al., 2003]. The 
difference between these previous results and those reported here might result from the 
primer set used for HPV PCR. Although the original GP5+/6+ primer set has been used in 
many epidemiological studies, it does not amplify HPV-52 as effectively as HPV-16 and 
HPV-18 because of sequence mismatches between the target gene and the primers [Yamada 
et al., 2008, Miyashita et al., 2009]. Thus, studies using only the GP5+/6+ primer set could 
have underestimated HPV-52 prevalence. In this study, modified GP5+/6+ primer sets were 
used together with the original set to broaden the spectrum of detectable HPV types 
[Miyashita et al., 2009].  
 In the current study, the risk of HPV infection was significantly higher in women ≤ 25 
years than in women > 25 years of age (OR = 2.1, 95% CI: 1.4–3.9). This finding is 
consistent with previous reports that the prevalence of HPV is age dependent, with a peak in 
young women after the onset of sexual activity [Molano et al., 2003; Miyashita et al., 2009]; 
one explanation might be that in young women, there is a higher probability of exposure to 
HPV and less acquired immunity to HPV from past exposure. Thus, younger women would 
benefit more from HPV vaccination programs.  
 Smoking increases the risk of squamous-cell carcinoma of the cervix. However, 
previous studies have found a negative [Ho et al., 1998], positive [Minkoff et al., 2004; Pista 
et al., 2012], or null [Vaccarella et al., 2008] association between smoking and HPV infection 
over time. In this study, ever smoking was associated with a lower risk of HPV infection, 
although the protective mechanism of smoking against HPV infection and whether it is a 
biologic or a confounding effect are unknown. 
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 Among the female sex workers in Northern Vietnam, HPV infection was the most 
prevalent (49.5%), followed by HCV (18.5%), HIV (12.8%), HBV (6.8%), C. trachomatis 
(6.8%), and N. gonorrhoeae (1.4%) infections. Of these infections, only HIV infection had a 
significantly higher association with HPV infection in the women in the current study (OR: 
7.9; 95% CI: 3.1–20.2), which is consistent with previous reports that HIV-related 
immunosuppression increases the risk of genital HPV infection and affects HPV replication 
[Ho et al., 1994]. Humoral immune responses are altered within a few months after HIV 
infection [Marais et al., 2009], which may reduce the ability of women infected with HIV to 
produce HPV-specific secretory IgA antibodies, resulting in an increase in the HPV infection 
rate. It was also reported that HPV infections are more likely to persist in women infected 
with HIV compared to women not infected with HIV [Clifford et al., 2006; Luchters et al., 
2010].  
In this study, the Pap smear test revealed that only nine women (3.2%) had 
“abnormal” cervical cytology (four with atypical glandular cells/atypical squamous cells of 
undetermined significance, four with a low-grade squamous intraepithelial lesion, and one 
with a high-grade squamous intraepithelial lesion). The frequency of abnormal cervical 
cytology in this study is much lower than that among female sex workers in the Philippines 
(15.2%)[Miyashita et al., 2009] and Japan (12.8%)[Matsushita et al., 2011]. The difference 
might be due to whether those study subjects were active female sex workers (in the studies 
of the Philippines and Japan) or not (in this study). However, considering that the HPV 
prevalence in this study is similar to that among female sex workers in those previous studies 
[Miyashita et al., 2009; Matsushita et al., 2011], the possibility that collection and fixation of 
cervical swab samples were done under limited conditions, which affected the Pap smear 
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analysis, could not be excluded completely in this study. All nine of the women with 
abnormal cervical cytology were infected with one or more high-risk HPV types. Thus, the 
correlation between infection with high-risk HPV types and abnormal cervical cytology was 
confirmed. Although population-based Pap smear screening has been introduced in Vietnam, 
only 4.9% of the general population of women ages 18–69 years have undergone the 
screening [WHO, 2010], and cervical cancer has become progressively a leading cause of 
cancer-related death among women in Vietnam [Domingo et al., 2008]. Considering these 
data, an active program is needed to control cervical cancer effectively using not only the Pap 
smear test but also the cervical HPV DNA test in Vietnam.  
In conclusion, HPV-52 was the most prevalent high-risk HPV type among female sex 
workers in Northern Vietnam, most of whom had normal cervical cytology. Age ≤ 25 years 
and HIV infection were associated positively with HPV infection among the women and ever 
smoking was associated negatively. These findings suggest that the current HPV vaccines 
targeting HPV-16 and HPV-18 may not be sufficient to prevent infection with high-risk HPV 
types in this region. Thus, second-generation HPV prophylactic vaccines that include HPV-
52 might be necessary to prevent HPV infection in Northern Vietnam. However, the clinical 
relevance of the use of new vaccines that include other high-risk types such as HPV52 was 
not demonstrated in this work. Even though HPV52 was the most prevalent type, it was not 
found to be related to a high-grade squamous intraepithelial lesion, but was HPV16. It is, 
therefore, important to investigate the prevalence of HPV-52 among patients with cervical 
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Figure 1: Prevalence of HPV genotypes among female sex workers in Northern Vietnam. 
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TABLE I. Risk factors associated with HPV infection. 
   FSWa HPV DNA (+)   Univariate   Multivariate 
  cases n %  ORb 95% CI P  ORb 95% CI P 
Age (years) ≤25 138 82 59.4  2.2 1.4–3.6 0.001  2.3 1.4–3.9 0.001 
 >25 143 57 39.9  1       
Age 

















0.7–1.9 0.467     
             
Marital status Single 139 80 57.6  1.9 1.2–3.1 0.009     
 Married/ 
cohabiting 
142 59 41.5  1       
Education level ≥ Secondary 193 98 50.8  1.2 0.7–2.0      
 < Secondary 88 41 46.6  1       
Pregnancy history Yes 203 95 46.8  0.7 0.4–1.2 0.183     
 No 78 44 56.4  1       
Contraception use Yes 227 114 50.2  1.1 0.6–2.1 0.761     
 No 53 25 47.2  1       
Condom use Yes 133 63 47.4  0.8 0.5–1.3 0.476     
 No 147 76 51.7  1       
Smoking Ever 101 41 40.6  0.6 0.3–0.9 0.025  0.5 0.3–0.8 0.006 
 Never 178 98 55.1  1       
HIV Positive 36 28 77.8  4.2 1.9–9.6 <0.001  7.9 3.1–20.2 <0.001 
 Negative 245 111 45.3  1       
HBV Positive 19 11 57.9  1.4 0.6–3.7 0.484     
 Negative 262 128 48.9  1       
HCV Positive 52 25 48.1  0.9 0.5–1.7 0.878     
 Negative 228 114 50.0  1       
N. gonorrhoeae Positive 4 3 75  3.1 0.3–30.3 0.367     
 Negative 277 136 49.1  1       
C. trachomatis Positive 19 13 68.4  2.3 0.9–6.3 0.1     
 Negative 262 126 48.1  1       
a FSW: female sex workers. b Odds ratio adjusted for all variables. 




          
  






 HPV Types 





HPV-2-118 28 No   39, 68 
HPV-2-201 21 Yes HIV, HCV  59 
Atypical glandular 
cells (2) 
HPC-028-09 29 No HIV  16, 52 
HPV-2-176 23 No N. gonorrhoeae 
C. trachomatis 






HPV-2-119 17 No HIV 
C. trachomatis 
6, 42, 54 35, 51, 68 
HPV-2-124 30 Yes HIV, HCV  66 
HPV-2-127 27 Yes   51,52 





HPC-048-09 48 Yes   16 
   HIV: human immunodeficiency virus; HPV: human papillomavirus; HCV: hepatitis C virus;  
N. gonorrhoeae: Neisseria gonorrhoeae; C. trachomatis: Chlamydia (C.) trachomatis.   
















HPV genotypes (n = 29) 
